Motor Neurone Disease & NHS Continuing Healthcare
MND moves fast. NHS funding must move faster.
Motor neurone disease produces some of the most rapidly escalating care needs in any condition. It affects breathing, swallowing, communication, and mobility — often simultaneously, and often within months. Families who do not secure CHC funding early are left paying privately during the very period when their loved one’s needs — and costs — are at their highest.
Last reviewed June 2026 · Based on the National Framework for NHS Continuing Healthcare (revised 2022).
Why MND almost always qualifies for CHC
Motor neurone disease causes progressive degeneration of the motor neurones controlling movement, speech, swallowing, and breathing. There is no treatment that stops or reverses progression. The condition moves rapidly — sometimes over months, sometimes over a few years — and the resulting care needs are among the most clinically complex of any condition encountered in the CHC assessment framework.
MND is not a condition where CHC eligibility is marginal. In the majority of cases with significant disease progression, the level of care required across multiple domains — breathing, communication, swallowing, mobility, and drug therapy management — is clearly sufficient to constitute a primary health need. The question is not usually whether a person with MND qualifies, but whether the process moves quickly enough for funding to be in place when it is needed.
This is why the Fast Track CHC pathway is particularly important in MND. A clinician who forms the view that the condition is rapidly deteriorating — which, in MND, is almost always the case — can initiate Fast Track at any point. Families should not wait to be offered this. Ask the neurologist or MND nurse specialist to consider Fast Track CHC at the earliest opportunity.
Which CHC domains MND most commonly affects
Breathing
Respiratory failure is the most common cause of death in MND. As the respiratory muscles weaken, non-invasive ventilation (NIV/BiPAP) is introduced, followed in some cases by invasive mechanical ventilation. The management of respiratory support in MND requires specialist nursing skill and round-the-clock clinical vigilance. This domain should score Priority in any person with MND requiring ventilatory support.
Nutrition, food and drink
Dysphagia is an early and progressive feature of MND, particularly in bulbar-onset disease. As swallowing deteriorates, the risk of aspiration pneumonia increases. PEG (percutaneous endoscopic gastrostomy) feeding is often required. The clinical management of PEG feeding and the monitoring of nutritional status requires skilled nursing input and must be reflected in this domain.
Communication
Loss of speech is a defining and often devastating feature of MND. As dysarthria progresses, augmentative and alternative communication (AAC) devices become essential. The complexity of supporting a person whose communication is severely impaired — including their ability to express pain, distress, and clinical needs — is clinically significant and must be captured in this domain.
Mobility
Progressive paralysis creates a high-intensity mobility picture — full hoisting for all transfers, pressure area management in a person who cannot reposition independently, and the prevention of contractures. The level of nursing skill and frequency of intervention required must be accurately reflected.
Drug therapies and medication
Symptom management in MND involves complex polypharmacy: riluzole, muscle relaxants for spasticity, antisecretory agents for drooling and secretion management, anxiolytics for breathlessness and anxiety, and anticipatory prescribing for end-of-life. Syringe driver management is common in the final stages. This domain should score Severe or Priority.
What evidence matters for an MND assessment
Evidence that carries weight in MND CHC assessments:
- Neurology clinic letters documenting disease type (limb-onset, bulbar-onset, respiratory-onset), current functional level, and rate of progression
- MND nurse specialist records and any multidisciplinary clinic documentation
- Respiratory function tests (FVC %) and respiratory clinic letters
- SALT assessment documenting dysphagia severity and PEG status
- Communication aid documentation from speech and language therapy
- Current medication regime and any anticipatory prescribing documentation
- A carer’s account of the pace of deterioration and the current level of care required
Acting early: the most important thing families can do
The single most important action a family can take when a loved one is diagnosed with MND is to initiate the CHC process early — before the clinical situation becomes urgent.
MND progresses faster than the CHC process moves. By the time a family realises funding is needed, the person’s condition may have deteriorated beyond the point where the standard assessment pathway can deliver a timely outcome. The Fast Track pathway exists to address this — but even Fast Track processing takes time, and in one 2023 hospital study nearly a third of Fast Track patients died before funded care was arranged.
Ask the neurologist or MND nurse specialist to raise CHC eligibility at the first multidisciplinary clinic appointment after diagnosis. Do not wait for the clinical team to bring it up. If the condition is already significantly progressed, request Fast Track immediately.
Sources & further reading
The guidance on this page is grounded in the National Framework and reputable clinical sources. Always check the current version of each:
- National Framework for NHS Continuing Healthcare (gov.uk, revised 2022)
- NHS Continuing Healthcare Fast Track Pathway Tool (gov.uk)
- NHS — Motor neurone disease
- NICE NG42 — Motor neurone disease: assessment and management
- MND Association — NHS Continuing Healthcare
Frequently asked questions
Should a person with MND always use the Fast Track CHC pathway?
In most cases of significant MND progression, yes. The Fast Track pathway is available whenever a clinician forms the view that the condition is rapidly deteriorating and may be entering a terminal phase — a description that applies to the majority of people with MND once the condition has progressed to the point of significant care need. Ask the neurologist or MND nurse specialist to consider Fast Track CHC at the earliest opportunity. The standard pathway is too slow for a condition that moves as quickly as MND.
What if CHC funding is not in place when a person with MND needs urgent care?
If your loved one needs care urgently and CHC funding is not yet in place, do not delay care. Arrange care privately if necessary and keep all invoices and payment records. If CHC eligibility is subsequently confirmed, you may be able to recover costs from the date of eligibility through the retrospective claims process. A specialist CHC solicitor can advise on the viability of a retrospective claim and the period it could cover.
Can a person with MND qualify for CHC from diagnosis, or only in the later stages?
CHC eligibility depends on the person’s current care needs, not their prognosis or disease stage. Early-stage MND may not produce care needs that meet the threshold. However, as the condition progresses — typically within months for bulbar-onset disease and within a year or two for limb-onset — the care needs of most people with MND will clearly meet the CHC threshold. The key is to initiate the process early, so that funding is in place before the situation becomes acute.